SynCardia's Freedom® Portable Driver
Selected as Silver Winner at Edison Awards
World's First Wearable Power Supply for the SynCardia Total Artificial Heart
Honored as Game-Changing Innovation at the Forefront of New Product Development
TUCSON, Ariz. – May 2, 2013 – SynCardia Systems, Inc., manufacturer of the world's first and only FDA, Health Canada and CE (Europe) approved Total Artificial Heart, announced today that its Freedom® portable driver, the world's first wearable power supply for the SynCardia temporary Total Artificial Heart, was named the 2013 Silver Winner amongst Assistive Devices in the Science/Medical category of the Edison Awards on April 25 in Chicago.
"The awards demonstrate the incredible range and pace of innovation globally and across a wide variety of industries," said Frank Bonafilia, executive director of the Edison Awards. "It is important that such excellence in innovation be widely recognized and done so in the spirit of the world's greatest inventor."
Weighing 13.5 pounds, the Freedom portable driver allows stable Total Artificial Heart patients who meet discharge criteria to wait for a matching donor heart at home and in their communities instead of in the hospital. To date, the Freedom portable driver has supported 130 patients worldwide, accounting for more than 55 patient years of support.
The Edison Awards have been recognizing and honoring the best in innovations and innovators since 1987. The awards honor game-changing innovations that are at the forefront of new product and service development, marketing and human-centered design, and are one of the highest accolades a company can receive in the name of successful innovation.
Winners were judged by a panel of more than 3,000 peers, including business executives, past winners, academics and leaders in the fields of product development, design, engineering, science and medicine. Sponsors of the 2013 Edison Awards included Nielsen, Discovery Communications, McAndrews Held & Malloy, Science Channel and USA Today.
The Freedom portable driver is CE approved for use in Europe and undergoing an FDA-approved Investigational Device Exemption (IDE) clinical study in the U.S.
CAUTION – The Freedom portable driver is an investigational device, limited by United States law to investigational use.
About SynCardia Systems, LLC
SynCardia Systems, LLC in Tucson, Ariz., is the privately-held manufacturer of the world's first and only FDA, Health Canada and CE approved Total Artificial Heart. For people suffering from end-stage heart failure affecting both sides of the heart (biventricular failure), the SynCardia temporary Total Artificial Heart is used as a bridge to transplant, helping them survive until a matching donor heart becomes available. SynCardia also manufactures the Freedom® portable driver, which powers the SynCardia Total Artificial Heart and allows clinically stable patients to be discharged from the hospital to enjoy life at home while they wait for a heart transplant.
Janelle Drumwright, email@example.com, (520) 547-7463